Monarch Robotic Bronchoscopy fights lung cancer at St. Joseph's/Candler
A new era in early and accurate lung cancer detection
The thoracic (lung) cancer team at the Nancy N. and J.C. Lewis Cancer & Research Pavilion now has powerful technology in the fight against lung cancer: Monarch Robotic Bronchoscopy. This state-of-the-art technology allows for earlier, more precise diagnoses of small and hard-to-reach lung nodules, offering patients a non-invasive treatment option with fewer risks and improved accuracy.
The Monarch Platform is a blend of robotics, software, and data science that powers accurate and rapid diagnosis. Physicians can use advanced tools and a controller-like interface, similar to a video game console, to guide a flexible robotic endoscope deep into the lungs with greater precision and control than ever before. The platform also utilizes 3D models of the patient’s unique lung anatomy, providing continuous, real-time navigation throughout the procedure.
Key benefits of the Monarch robot
Patients and physicians alike benefit from the innovative capabilities of the Monarch Platform:
- Earlier diagnosis, increasing the chances of survival
- Improved outcomes through precise detection and treatment planning
- Enhanced physician capabilities with advanced navigation and visualization
- Reduced false positives and false negatives
- Minimized side effects from less invasive procedures

How Monarch technology enhances patient care
Collaborative expertise meets cutting-edge tools
At the Lewis Cancer & Research Pavilion, a team of pulmonologists, surgeons, radiation oncologists, medical oncologists, and other specialists creates personalized care plans for each patient. This approach ensures that every case is evaluated with the utmost expertise and exactitude.
When a patient presents suspicious findings on a lung CT scan, a pulmonologist can use the Monarch platform to perform a quick, accurate biopsy. The Monarch helps confirm whether the findings are cancerous by accessing small or hard-to-reach lung nodules. These biopsy results, combined with imaging and other diagnostic tools, guide the team in recommending the most effective treatment plan, whether that involves surgery, radiation or other effective therapies.
The Monarch Platform can also place dyes or fiducials to accurately mark tumors and make surgery less invasive.